Pulmonary-Renal vasculitic disorders: Differential diagnosis and management

Current Rheumatology Reports

Volumn 5, Issue 2, 2003, Pages 107-115

  Jara, Luis J ^a   Vera Lastra, Olga ^b   Calleja, Maria C ^b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b NONE

Author keywords

Alveolar Hemorrhage; Crescentic Glomerulonephritis; Pulmonary Hemorrhage; Systemic Vasculitis; Vasculitis

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT;

CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; GLOMERULONEPHRITIS; HUMAN; KIDNEY; LUNG; PATHOLOGY; REVIEW; VASCULITIS;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; BIOLOGICAL MARKERS; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUNG; VASCULITIS;

EID: 0037706788     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-003-0038-0     Document Type: Article

References (52)

1. Goodpasture EW: The significance of certain pulmonary lesions in relation to the etiology of pneumonia. Am J Med Sci 1919, 158:863–870. DOI: 10.1097/00000441-191911000-00012
2. Stanton MC, Tange JD: Goodpasture’s syndrome (pulmonary hemorrhage associated with glomerulonephritis). Austr Ann Med 1958, 7:132–144.
3. Lerner RA, Glassock KJ, Dixon FJ: The role of antiglomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967, 126:989–1004. DOI: 10.1084/jem.126.6.989
4. Peters DK, Rees AJ, Lockwood CM, Pusey CD: Treatment and prognosis in antibasement membrane antibody-mediated nephritis. Transplant Proc 1982, 14:513–521.
5. Saus J, Wieslander J, Langeveld JPM, et al.: Identification of the Goodpasture antigen as the alpha-3 chain (IV) chain of collagen IV. J Biol Chem 1988, 263:13374–13380.
6. Boch X, Font J: The pulmonary-renal syndrome: a poorly understood clinicopathologic condition. Lupus 1999, 8:258–262. The authors suggest that the type of glomerular or alveolar immunologic injury is the main factor in determining the outcome and prognosis of the PRS. DOI: 10.1191/096120399678847740
7. Bolton WK: Goodpasture’s syndrome. Kidney Int 1996, 50:1753–1766. DOI: 10.1038/ki.1996.495
8. Jayne DRW: Severe pulmonary hemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasm antibodies of IgM class only. Clin Nephrol 1989, 32:101–106.
9. Barile LA, Jara LJ, Medina-Rodriguez F, et al.: Pulmonary hemorrhage in systemic lupus erythematosus. Lupus 1997, 6:445–448.
10. Saxena R, Bygren P, Arvastson B, Wieslander J: Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome. J Intern Med 1995, 238:143–152. DOI: 10.1111/j.1365-2796.1995.tb00912.x
11. Niles JL, Bottinger EP, Saurina GR, et al.: The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996, 156:440–445. DOI: 10.1001/archinte.156.4.440
12. Turner N, Mason PJ, Brown R, et al.: Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha-3 chain of type IV collagen. J Clin Invest 1992, 89:592–601. DOI: 10.1172/JCI115625
13. Ball JA, Young KR: Pulmonary manifestations of Goodpasture ’s syndrome. Clin Chest Med 1998, 19:777–791. DOI: 10.1016/S0272-5231(05)70116-7
14. Hellmark T, Segelmark M, Wieslander J: Anti-GBM antibodies in Goodpasture’s syndrome; anatomy of an epitope. Nephrol Dial Transplant 1997, 12:646–648. DOI: 10.1093/ndt/12.4.646
15. David M, Borza D-B, Leinonen A, et al.: Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. J Biol Chem 2001, 276:6370–6377. This is a basic article for the understanding of the etiology and pathogenesis of GPS. DOI: 10.1074/jbc.M008956200
16. Salama AD, Chaudhry AN, Ryan JJ, et al.: In Goodpasture’s disease, CD4 + T cells escape thymic deletion and are reactive with the autoantigen alpha-3 (IV) NC1. J Am Soc Nephrol 2001, 12:1908–1915. Very interesting study that shows characteristics of autoreactive T cells in GPS. The principal finding is the decrease in time of autoreactive T cell.
17. Luo A-M, Fox JW, Chen L, Bolton K: Synthetic peptides of Goodpasture’s antigen in antiglomerular basement membrane nephritis in rats. J Lab Clin Med 2002, 139:303–310. This study suggest that more than one antigen is necessary to produce this type of nephritis in GPS. DOI: 10.1067/mlc.2002.123623
18. Fox HL, Swann D: Goodpasture’s syndrome: pathophysiology, diagnosis, and management. Nephrol Nurs J 2001, 28:305–310. An excellent review of GPS.
19. Phelps RG, Rees AJ: The HLA complex in Goodpasture’s disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 1999, 56:1638–1653. DOI: 10.1046/j.1523-1755.1999.00720.x
20. Wiik AS: Clinical use of serological tests for antineutrophil cytoplasmic antibodies: what do the studies say? Rheum Dis Clin North Am 2001, 27:799–813. DOI: 10.1016/S0889-857X(05)70236-2
21. Kamesh L, Harped L, Savage COS: ANCA-positive vasculitis. J Am Soc Nephrol 2002, 13:1953–1960. DOI: 10.1097/01.ASN.0000016442.33680.3E
22. Brouwer E, Huitema MG, Klok PA, et al.: Anti-myeloperoxidase associated proliferative glomerulonephritis: an animal model. J Exp Med 1993, 177:905–914. DOI: 10.1084/jem.177.4.905
23. Foucher P, Heeringa P, Petersen AH, et al.: Antimyeloperoxidase-associated lung disease: an experimental model. Am J Respir Crit Care Med 1999, 160:987–994. This group continues the investigation of the role of ANCA in experimental vasculitis. In this article, they demonstrate alveolar hemorrhage induced by anti-MPO.
24. Morita S, Ueda Y, Eguchi K: Anti-thyroid drug-induced ANCAassociated vasculitis: a case report and review of the literature. Endocr J 2000, 47:467–470.
25. Garcia-Rostand Y, Perez GM, Garcia Bragado F, Puras-Gil AM: Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature. Pathol Int 1997, 47:692–697. DOI: 10.1111/j.1440-1827.1997.tb04443.x
26. Yashiro M, Muso E, Itoh-Ihara T, et al.: Significantly high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kidney Dis 2000, 35:889–895. Very interesting epidemiologic and clinical observations that suggests the role of environmental factors (asbestos and silica) in the etiopathogenesis of PRS-ANCA-associated.
27. Brener Z, Cohen L, Goldberg SJ, Kaufman AM: ANCA-associated vasculitis in Greek siblings with chronic exposure to silica. Am J Kidney Dis 2001, 38:E28. Very interesting clinical observation that supports the role of environmental and genetic factors in the pathogenesis and clinical expression of PRS.
28. Gallagher H, Kwan JT, Jayne DRW: Pulmonary-renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002, 39:42–47. This is one of the first articles to describe long-term follow-up of PRS.
29. Turner AN: Goodpasture’s disease. Nephrol Dial Transplant 2001, 16(suppl):52–54. This is a very complete review that enhances the role of GPS as a model of autoimmune kidney damage. DOI: 10.1093/ndt/16.1.52
30. Salama AD, Levy JB, Lighstone L, Pusey CD: Goodpasture’s disease. Lancet 2001, 358:917–920. An excellent review with emphasis in clinical features of GPS. DOI: 10.1016/S0140-6736(01)06077-9
31. Kluth DC, Rees AJ: Anti glomerular basement membrane disease. J Am Soc Nephrol 1999, 10:2446–2453.
32. Fervenza FC, Terreros D, Boutaud A, et al.: Recurrent Goodpasture ’s disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis 1999, 34:549–555.
33. Carreras L, Poveda R, Bas J, et al.: Goodpasture’s syndrome during the course of a Schönlein-Henoch purpura. Am J Kidney Dis 2002, 39:21. DOI: 10.1053/ajkd.2002.32799
34. Lettieri C, Pina J: Goodpasture’s syndrome: a case of delayed appearance of autoantibodies and renal disease. Mil Med 2001, 169:827–830.
35. Salama AD, Dougan T, Levy JB, et al.: Goodpasture’s disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis 2002, 39:1162–1167. DOI: 10.1053/ajkd.2002.33385
36. Dougan T, Levy JB, Salama AD, et al.: Characterization of autoantibodies from patients with Goodpasture’s disease using a resonant mirror biosensor. Clin Exp Immunol 2002, 128:555–561. Optical biosensor technology may be a useful and practical method to determinate antibodies anti-GBM and others without the need for antibody purification. DOI: 10.1046/j.1365-2249.2002.01867.x
37. Green RJ, Ruoss SJ, Kraft SA, et al.: Pulmonary capillaritis and alveolar hemorrhage: update on diagnosis and management. Chest 1996, 110:1305–1316.
38. Kallay N, Dunagan DP, Adair N, et al.: Hemoptysis in patients with renal insufficiency: the role of flexible bronchoscopy. Chest 2001, 119:788–794. This an interesting experience to asses the indications, yield, and therapeutic impact of flexible bronchoscopy in patients with hemoptysis and renal failure. In PRS, this method has a limited use. DOI: 10.1378/chest.119.3.788
39. Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 1997, 337:1512–1523. DOI: 10.1056/NEJM199711203372106
40. Lauque D, Cadranel J, Lazor R, et al.: Microscopic polyangiitis with alveolar hemorrhage: a study of 29 cases and review of the literature. Medicine (Baltimore) 2000, 79:222–233. This is a retrospective, multicenter study about clinical presentation of pulmonary manifestations of MPA with particular attention on short- and long-term course. DOI: 10.1097/00005792-200007000-00003
41. Hughson MD, He Z, Henegar J, McMurray R: Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus: immune complex small vascular injury with apoptosis. Arch Pathol Lab Med 2001, 125:475–483. This clinical and histopatologic study strongly supports the role of immune complex deposition and apoptosis in PRS.
42. Bar J, Ehrenfeld M, Rozenman J, et al.: Pulmonary renal syndrome in systemic sclerosis. Semin Arthritis Rheum 2001, 30:403–410. Pulmonary-renal syndrome in SSc is a rare, but fatal, complication that is associated with fibrosing alveolitis or D-penicilamine treatment. This article reviews all cases described in literature. DOI: 10.1053/sarh.2001.21904
43. Wutzl AL, Foley RN, O’Driscoll BR, et al.: Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Rheum 2001, 45:533–536. DOI: 10.1002/1529-0131(200112)45:6<533::AID-ART379>3.0.CO;2-D
44. Oide T, Iwamura A, Yamamoto H, et al.: Elderly-onset anticentromere antibody-positive pulmonary-renal syndrome: report of an autopsy case. Nihon Kokyuki Gakkai Zasshi 2001, 39:498–503.
45. Sano K, Sakaguchi N, Ito M, et al.: Histological diversity of vasculitic lesions in MPO-ANCA-positive autopsy cases. Pathol Int 2001, 51:460–466. This article shows the wide spectrum of tissue lesions in patients with vasculitis p-ANCA positive. DOI: 10.1046/j.1440-1827.2001.01225.x
46. von Vigier RO, Trummler SA, Laux-End R, et al.: Pulmonary renal syndrome in childhood: a report of twenty-one cases and a review of the literature. Pediatr Pulmonol 2000, 29:382–388. Little is known about PRS in children. This is the article with the most number of cases in children with PRS. DOI: 10.1002/(SICI)1099-0496(200005)29:5<382::AID-PPUL7>3.0.CO;2-D
47. Blanco-Filho F, Ernesto LC, Rosa MA, et al.: Rapidly progressive antineutrophil cytoplasm antibodies associated with pulmonary-renal syndrome in a 10-year-old girl. Sao Paulo Med J 2001, 119:29–32.
48. Gertner E, Lie JT: Pulmonary capillaritis, alveolar hemorrhage and recurrent icovascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 1993, 20:1224–1228.
49. Amigo MC, Garcia-Torres R, Robles M, et al.: Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992, 19:1181–1185.
50. Henning BF, Grone HJ, Tepel M, et al.: A rare cause of pulmonary-renal syndrome. Nephron 2002, 91:51–60. This is a first description of PRS in primary antiphospholipid syndrome. DOI: 10.1159/000064300
51. Giri P, Taylor JE: Recurrent Goodpasture’s disease with severe renal involvement after initial successful treatment. Nephrol Dial Transplant 2001, 16:1952–1960. DOI: 10.1093/ndt/16.9.1952
52. Jeremy B, Levy JB, Turner N, et al.: Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001, 134:1033–1042. This is an excellent study of long-term outcome of GPS with emphasis in kidney damage and treatment.